论文部分内容阅读
耐万古霉素肠球菌(VRE)是日益增多的不再对以前有效的抗生素敏感的病原菌之一。据美国疾病控制和预防中心(CDC)统计,从医院内肠球菌感染患者分离到的耐万古霉素肠球菌发生率从1989年的0.3%骤升至1993年的7.9%。80年代末,已有数个医院报道了VRE的流行。与此同时,肠球菌还对许多其他抗生素产生耐药,如青霉素和头孢菌素,增加了治疗的复杂性。CDC强调了慎用抗生素和采用有力的控制感染预防措施在防止VRE传播中的重要性。
Vancomycin-resistant Enterococcus (VRE) is one of the growing pathogens that are no longer sensitive to previously effective antibiotics. According to the Centers for Disease Control and Prevention (CDC), the incidence of vancomycin-resistant Enterococci isolates from hospital-acquired enterococci infections soared from 0.3% in 1989 to 7.9% in 1993. In the late 1980s, several hospitals reported the prevalence of VRE. In the meantime, enterococci also develop resistance to many other antibiotics, such as penicillin and cephalosporins, increasing the complexity of the treatment. The CDC emphasizes the importance of careful antibiotics and the use of potent infection-control measures to prevent the spread of VRE.